Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma

por Kadowaki, Shigenori, Yatabe, Yasushi, Hirakawa, Hitoshi, Komori, Azusa, Kondoh, Chihiro, Hasegawa, Yasuhisa, Muro, Kei
Publicado 2013

A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer

por Yamaguchi, Kazuhisa, Taniguchi, Hiroya, Komori, Azusa, Narita, Yukiya, Nitta, Sohei, Nomura, Motoo, Kadowaki, Shigenori, Takahari, Daisuke, Ura, Takashi, Andoh, Masashi, Muro, Kei, Mori, Keita, Igarashi, Yoshinori
Publicado 2015

Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature

por Mitani, Seiichiro, Kadowaki, Shigenori, Komori, Azusa, Sugiyama, Keiji, Narita, Yukiya, Taniguchi, Hiroya, Ura, Takashi, Ando, Masashi, Sato, Yozo, Yamaura, Hidekazu, Inaba, Yoshitaka, Ishihara, Makoto, Tanaka, Tsutomu, Tajika, Masahiro, Muro, Kei
Publicado 2017

Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab–paclitaxel or FOLFIRINOX: A post–hoc analysis of a multicenter retrospective...

por Shibuki, Taro, Mizuta, Toshihiko, Shimokawa, Mototsugu, Koga, Futa, Ueda, Yujiro, Nakazawa, Junichi, Komori, Azusa, Otsu, Satoshi, Arima, Shiho, Fukahori, Masaru, Makiyama, Akitaka, Taguchi, Hiroki, Honda, Takuya, Mitsugi, Kenji, Nio, Kenta, Ide, Yasushi, Ureshino, Norio, Shirakawa, Tsuyoshi, Otsuka, Taiga
Publicado 2022

C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel

por Shirakawa, Tsuyoshi, Makiyama, Akitaka, Shimokawa, Mototsugu, Otsuka, Taiga, Shinohara, Yudai, Koga, Futa, Ueda, Yujiro, Nakazawa, Junichi, Otsu, Satoshi, Komori, Azusa, Arima, Shiho, Fukahori, Masaru, Taguchi, Hiroki, Honda, Takuya, Shibuki, Taro, Nio, Kenta, Ide, Yasushi, Ureshino, Norio, Mizuta, Toshihiko, Mitsugi, Kenji, Akashi, Koichi, Baba, Eishi
Publicado 2023

Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer

por Fukahori, Masaru, Okabe, Yoshinobu, Shimokawa, Mototsugu, Otsuka, Taiga, Koga, Futa, Ueda, Yujiro, Nakazawa, Junichi, Komori, Azusa, Otsu, Satoshi, Arima, Shiho, Makiyama, Akitaka, Taguchi, Hiroki, Honda, Takuya, Ushijima, Tomoyuki, Miwa, Keisuke, Shibuki, Taro, Nio, Kenta, Ide, Yasushi, Ureshino, Norio, Mizuta, Toshihiko, Mitsugi, Kenji, Shirakawa, Tsuyoshi
Publicado 2023